The company uses automated machines at its Massachusetts plant for drug production, setting it apart from other American factories lagging in AI implementation. This highlights a strategic advantage in efficiency and innovation in pharmaceutical manufacturing.
President Trump's recent actions suggest a more favorable stance towards the cannabis sector. This includes federal funding for marijuana research, benefiting companies like Beak & Skiff in LaFayette, NY.
Higher health insurance premiums under Obamacare have led to a sharp decline in enrollment. The increase in costs stems from congressional decisions, making the program less accessible for many Americans.